Xeris Biopharma Holdings XERS
NASDAQ XERS
$10.20 -0.66 (-6.08%)
At close: Oct 23, 2026 · 4:00 PM EDT

Xeris Biopharma Holdings (XERS) Sale and Maturity of Investments (2020 - 2024)

Updated

Analysis

Xeris Biopharma Holdings (XERS) Sale and Maturity of Investments (2020 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Xeris Biopharma Holdings 1.77 Bn 1.33 Bn 79.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 10.24 Mn
Sep 30, 2024 15.00 Mn
Jun 30, 2024 10.00 Mn
Mar 31, 2024 5.00 Mn
Dec 31, 2023 15.00 Mn
Sep 30, 2023 15.00 Mn
Jun 30, 2023 10.00 Mn
Dec 31, 2022 9.30 Mn
Sep 30, 2022 6.89 Mn
Jun 30, 2022 12.10 Mn
Mar 31, 2022 6.70 Mn
Dec 31, 2021 10.50 Mn
Sep 30, 2021 29.45 Mn
Jun 30, 2021 29.00 Mn
Mar 31, 2021 34.65 Mn
Dec 31, 2020 17.84 Mn
API Access

Xeris Biopharma Holdings Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=XERS&period=max&api_key=YOUR_API_KEY